- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 141.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 136.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 117.97M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $980K |
| Capex | Q1 2026 · Mar 31, 2025 | $913K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$37.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$14.13M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $62.35M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $90.47M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $48.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $109.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $103.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $70.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $69.47M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $15.98M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $17.87M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $21.37M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $53.08M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $113.95M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $126.44M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $130.78M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $156.89M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $8.63M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.31M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.8M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.05M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$9.37M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.69M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$9.67M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $5.74M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$2.36M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $22.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $13.65M |